AREDS 2 and beyond - Lutein / Mesozeaxanthin and Zeaxanthin (45225-PS)

AdminWolf

Site Administrator & Tech Lead
Staff member
Feb 24, 2001
15,260
2,751
113
School/Org
University of Michigan Medical School
City
Lake Oswego
State
OR
Lecturer: @Stuart Richer

Synopsis:

We review how to identify the “high risk AMD patient” , the actual data within the JAMA publications and what it tells us about prevention of catastrophic vision loss in patients who have high risk of developing AMD. Next we explore what to tell the 90 % of patients who don’t have high risk AMD, yet are loosing vision from mild and moderate AMD that effects their night driving and overall visual performance. We explore Level 2 science about mesozeaxanthin and new instrumentation that are enhancing and invigorating the practice of optometry.

Register for CEwire2015 to listen to the recorded lecture & get CE Credit through August 17, 2015.

Discuss the lecture in the thread below.